APO Research
Talk to an analyst

APO RESEARCH · REPORT

Praziquantel

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Praziquantel Industry Growth and Trends Forecast to 2032

19 December 2025126 pages

Choose your research edition.

Industry ResearchPraziquantel Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Praziquantel Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Praziquantel Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Praziquantel Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Praziquantel market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Praziquantel include Zoetis, Merck, Bayer, Soparfin, Shin Poong Pharm, Richter Pharma, Norbrook Laboratories, Merial and Mavlab Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Praziquantel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Praziquantel market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Praziquantel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Praziquantel.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Praziquantel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Praziquantel Market by Company

Zoetis

Merck

Bayer

Soparfin

Shin Poong Pharm

Richter Pharma

Norbrook Laboratories

Merial

Mavlab Animal Health

Lavet Pharmaceuticals

Kyron Pharma

Krka

Ecuphar

Covetrus

CiplaVet

Chanelle Pharma

Ceva Santé Animale

C and H Generics

Auvex

AniMedica

Praziquantel Segment by Type

Patent

Generic

Praziquantel Segment by Application

Liver Fluke Infection

Cysticercosis

Cestode Infections

Trematode Infections

Schistosoma Infection

Others

Praziquantel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Praziquantel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Praziquantel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Praziquantel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Praziquantel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Praziquantel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patent Table 2. Major Company of Generic Table 3. Global Praziquantel Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Praziquantel Sales by Type (2021-2026) & (K Units) Table 5. Global Praziquantel Sales Market Share in Volume by Type (2021-2026) Table 6. Global Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 7. Global Praziquantel Sales Market Share in Value by Type (2021-2026) Table 8. Global Praziquantel Price by Type (2021-2026) & (US$/Unit) Table 9. Global Praziquantel Sales by Type (2027-2032) & (K Units) Table 10. Global Praziquantel Sales Market Share in Volume by Type (2027-2032) Table 11. Global Praziquantel Sales by Type (2027-2032) & (US$ Million) Table 12. Global Praziquantel Sales Market Share in Value by Type (2027-2032) Table 13. Global Praziquantel Price by Type (2027-2032) & (US$/Unit) Table 14. North America Praziquantel Sales by Type (2021-2026) & (K Units) Table 15. North America Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Praziquantel Sales by Type (2021-2026) & (K Units) Table 17. Europe Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Praziquantel Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Praziquantel Sales by Type (2021-2026) & (K Units) Table 21. Latin America Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Praziquantel Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Praziquantel Sales by Type (2021-2026) & (US$ Million) Table 24. Praziquantel Industry Trends Table 25. Praziquantel Industry Drivers Table 26. Praziquantel Industry Opportunities and Challenges Table 27. Praziquantel Industry Restraints Table 28. Global Praziquantel Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Praziquantel Revenue Market Share by Company (2021-2026) Table 30. Global Praziquantel Sales by Company (2021-2026) & (K Units) Table 31. Global Praziquantel Sales Share by Company (2021-2026) Table 32. Global Praziquantel Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Praziquantel Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Praziquantel Major Company Production Sites and Headquarters Table 35. Global Praziquantel Company, Product Type & Application Table 36. Global Praziquantel Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Praziquantel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Praziquantel Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Praziquantel Sales by Region (2021-2026) & (K Units) Table 41. Global Praziquantel Sales Market Share in Volume by Region (2021-2026) Table 42. Global Praziquantel Sales by Region (2021-2026) & (US$ Million) Table 43. Global Praziquantel Sales Market Share in Value by Region (2021-2026) Table 44. Global Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Praziquantel Sales by Region (2027-2032) & (K Units) Table 46. Global Praziquantel Sales Market Share in Volume by Region (2027-2032) Table 47. Global Praziquantel Sales by Region (2027-2032) & (US$ Million) Table 48. Global Praziquantel Sales Market Share in Value by Region (2027-2032) Table 49. Global Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Praziquantel Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Praziquantel Sales by Application (2021-2026) & (K Units) Table 52. Global Praziquantel Sales Market Share in Volume by Application (2021-2026) Table 53. Global Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 54. Global Praziquantel Sales Market Share in Value by Application (2021-2026) Table 55. Global Praziquantel Price by Application (2021-2026) & (US$/Unit) Table 56. Global Praziquantel Sales by Application (2027-2032) & (K Units) Table 57. Global Praziquantel Sales Market Share in Volume by Application (2027-2032) Table 58. Global Praziquantel Sales by Application (2027-2032) & (US$ Million) Table 59. Global Praziquantel Sales Market Share in Value by Application (2027-2032) Table 60. Global Praziquantel Price by Application (2027-2032) & (US$/Unit) Table 61. North America Praziquantel Sales by Application (2021-2026) & (K Units) Table 62. North America Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Praziquantel Sales by Application (2021-2026) & (K Units) Table 64. Europe Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Praziquantel Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Praziquantel Sales by Application (2021-2026) & (K Units) Table 68. Latin America Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Praziquantel Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Praziquantel Sales by Application (2021-2026) & (US$ Million) Table 71. Zoetis Company Information Table 72. Zoetis Business Overview Table 73. Zoetis Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zoetis Praziquantel Product Portfolio Table 75. Zoetis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Praziquantel Product Portfolio Table 80. Merck Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bayer Praziquantel Product Portfolio Table 85. Bayer Recent Development Table 86. Soparfin Company Information Table 87. Soparfin Business Overview Table 88. Soparfin Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Soparfin Praziquantel Product Portfolio Table 90. Soparfin Recent Development Table 91. Shin Poong Pharm Company Information Table 92. Shin Poong Pharm Business Overview Table 93. Shin Poong Pharm Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shin Poong Pharm Praziquantel Product Portfolio Table 95. Shin Poong Pharm Recent Development Table 96. Richter Pharma Company Information Table 97. Richter Pharma Business Overview Table 98. Richter Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Richter Pharma Praziquantel Product Portfolio Table 100. Richter Pharma Recent Development Table 101. Norbrook Laboratories Company Information Table 102. Norbrook Laboratories Business Overview Table 103. Norbrook Laboratories Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Norbrook Laboratories Praziquantel Product Portfolio Table 105. Norbrook Laboratories Recent Development Table 106. Merial Company Information Table 107. Merial Business Overview Table 108. Merial Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Merial Praziquantel Product Portfolio Table 110. Merial Recent Development Table 111. Mavlab Animal Health Company Information Table 112. Mavlab Animal Health Business Overview Table 113. Mavlab Animal Health Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mavlab Animal Health Praziquantel Product Portfolio Table 115. Mavlab Animal Health Recent Development Table 116. Lavet Pharmaceuticals Company Information Table 117. Lavet Pharmaceuticals Business Overview Table 118. Lavet Pharmaceuticals Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Lavet Pharmaceuticals Praziquantel Product Portfolio Table 120. Lavet Pharmaceuticals Recent Development Table 121. Kyron Pharma Company Information Table 122. Kyron Pharma Business Overview Table 123. Kyron Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Kyron Pharma Praziquantel Product Portfolio Table 125. Kyron Pharma Recent Development Table 126. Krka Company Information Table 127. Krka Business Overview Table 128. Krka Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Krka Praziquantel Product Portfolio Table 130. Krka Recent Development Table 131. Ecuphar Company Information Table 132. Ecuphar Business Overview Table 133. Ecuphar Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Ecuphar Praziquantel Product Portfolio Table 135. Ecuphar Recent Development Table 136. Covetrus Company Information Table 137. Covetrus Business Overview Table 138. Covetrus Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Covetrus Praziquantel Product Portfolio Table 140. Covetrus Recent Development Table 141. CiplaVet Company Information Table 142. CiplaVet Business Overview Table 143. CiplaVet Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. CiplaVet Praziquantel Product Portfolio Table 145. CiplaVet Recent Development Table 146. Chanelle Pharma Company Information Table 147. Chanelle Pharma Business Overview Table 148. Chanelle Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Chanelle Pharma Praziquantel Product Portfolio Table 150. Chanelle Pharma Recent Development Table 151. Ceva Santé Animale Company Information Table 152. Ceva Santé Animale Business Overview Table 153. Ceva Santé Animale Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Ceva Santé Animale Praziquantel Product Portfolio Table 155. Ceva Santé Animale Recent Development Table 156. C and H Generics Company Information Table 157. C and H Generics Business Overview Table 158. C and H Generics Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. C and H Generics Praziquantel Product Portfolio Table 160. C and H Generics Recent Development Table 161. Auvex Company Information Table 162. Auvex Business Overview Table 163. Auvex Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Auvex Praziquantel Product Portfolio Table 165. Auvex Recent Development Table 166. AniMedica Company Information Table 167. AniMedica Business Overview Table 168. AniMedica Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. AniMedica Praziquantel Product Portfolio Table 170. AniMedica Recent Development Table 171. North America Praziquantel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Praziquantel Sales by Country (2021-2026) & (K Units) Table 173. North America Praziquantel Sales Market Share by Country (2021-2026) Table 174. North America Praziquantel Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Praziquantel Sales Market Share Forecast by Country (2027-2032) Table 176. North America Praziquantel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Praziquantel Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Praziquantel Market Share by Country (2021-2026) Table 179. North America Praziquantel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Praziquantel Market Share Forecast by Country (2027-2032) Table 181. Europe Praziquantel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Praziquantel Sales by Country (2021-2026) & (K Units) Table 183. Europe Praziquantel Sales Market Share by Country (2021-2026) Table 184. Europe Praziquantel Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Praziquantel Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Praziquantel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Praziquantel Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Praziquantel Market Share by Country (2021-2026) Table 189. Europe Praziquantel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Praziquantel Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Praziquantel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Praziquantel Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Praziquantel Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Praziquantel Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Praziquantel Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Praziquantel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Praziquantel Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Praziquantel Market Share by Country (2021-2026) Table 199. Asia-Pacific Praziquantel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Praziquantel Market Share Forecast by Country (2027-2032) Table 201. Latin America Praziquantel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Praziquantel Sales by Country (2021-2026) & (K Units) Table 203. Latin America Praziquantel Sales Market Share by Country (2021-2026) Table 204. Latin America Praziquantel Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Praziquantel Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Praziquantel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Praziquantel Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Praziquantel Market Share by Country (2021-2026) Table 209. Latin America Praziquantel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Praziquantel Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Praziquantel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Praziquantel Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Praziquantel Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Praziquantel Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Praziquantel Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Praziquantel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Praziquantel Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Praziquantel Market Share by Country (2021-2026) Table 219. Middle East and Africa Praziquantel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Praziquantel Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Praziquantel Distributors List Table 224. Praziquantel Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Praziquantel Image Figure 2. Global Praziquantel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Praziquantel Market Size (2021-2032) & (US$ Million) Figure 4. Global Praziquantel Sales (2021-2032) & (K Units) Figure 5. Patent Image Figure 6. Global Patent Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Image Figure 8. Global Generic Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Praziquantel Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Praziquantel Market Share by Type 2025 VS 2032 Figure 11. North America Praziquantel Sales Market Share in Volume by Type in 2025 Figure 12. North America Praziquantel Sales Market Share in Value by Type in 2025 Figure 13. Europe Praziquantel Sales Market Share in Volume by Type in 2025 Figure 14. Europe Praziquantel Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Praziquantel Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Praziquantel Sales Market Share in Value by Type in 2025 Figure 17. Latin America Praziquantel Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Praziquantel Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Praziquantel Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Praziquantel Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Praziquantel Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Liver Fluke Infection Image Figure 24. Global Liver Fluke Infection Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cysticercosis Image Figure 26. Global Cysticercosis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cestode Infections Image Figure 28. Global Cestode Infections Sales YoY Growth (2021-2032) & (K Units) Figure 29. Trematode Infections Image Figure 30. Global Trematode Infections Sales YoY Growth (2021-2032) & (K Units) Figure 31. Schistosoma Infection Image Figure 32. Global Schistosoma Infection Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Praziquantel Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Praziquantel Market Share by Application 2025 VS 2032 Figure 37. North America Praziquantel Sales Market Share in Volume by Application in 2025 Figure 38. North America Praziquantel Sales Market Share in Value by Application in 2025 Figure 39. Europe Praziquantel Sales Market Share in Volume by Application in 2025 Figure 40. Europe Praziquantel Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Praziquantel Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Praziquantel Sales Market Share in Value by Application in 2025 Figure 43. Latin America Praziquantel Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Praziquantel Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Praziquantel Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Praziquantel Sales Market Share in Value by Application in 2025 Figure 47. North America Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Praziquantel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Praziquantel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Praziquantel Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Praziquantel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Praziquantel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Praziquantel Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Praziquantel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Praziquantel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Praziquantel Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Praziquantel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Praziquantel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Praziquantel Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Praziquantel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Praziquantel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Praziquantel Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Praziquantel Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Praziquantel Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Liver Fluke Infection
  • Cysticercosis
  • Cestode Infections
  • Trematode Infections
  • Schistosoma Infection
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer
  • Soparfin
  • Shin Poong Pharm
  • Richter Pharma
  • Norbrook Laboratories
  • Merial
  • Mavlab Animal Health
  • Lavet Pharmaceuticals
  • Kyron Pharma
  • Krka
  • Ecuphar
  • Covetrus
  • CiplaVet
  • Chanelle Pharma
  • Ceva Santé Animale
  • C and H Generics
  • Auvex
  • AniMedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Praziquantel Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Praziquantel Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Praziquantel Market by Type
  6. 1.3.1 Patent
  7. 1.3.2 Generic
  8. 1.4 Global Praziquantel Market Size by Type
  9. 1.4.1 Global Praziquantel Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Praziquantel Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Praziquantel Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Praziquantel Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Praziquantel Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Praziquantel Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Praziquantel Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Praziquantel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Praziquantel Industry Trends
  2. 2.2 Praziquantel Industry Drivers
  3. 2.3 Praziquantel Industry Opportunities and Challenges
  4. 2.4 Praziquantel Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Praziquantel Revenue (2021-2026)
  2. 3.2 Global Top Players by Praziquantel Sales (2021-2026)
  3. 3.3 Global Top Players by Praziquantel Price (2021-2026)
  4. 3.4 Global Praziquantel Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Praziquantel Major Company Production Sites & Headquarters
  6. 3.6 Global Praziquantel Company, Product Type & Application
  7. 3.7 Global Praziquantel Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Praziquantel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Praziquantel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Praziquantel Tier 1, Tier 2, and Tier 3
4 Praziquantel Regional Status and Outlook
  1. 4.1 Global Praziquantel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Praziquantel Historic Market Size by Region
  3. 4.2.1 Global Praziquantel Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Praziquantel Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Praziquantel Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Praziquantel Forecasted Market Size by Region
  7. 4.3.1 Global Praziquantel Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Praziquantel Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Praziquantel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Praziquantel by Application
  1. 5.1 Praziquantel Market by Application
  2. 5.1.1 Liver Fluke Infection
  3. 5.1.2 Cysticercosis
  4. 5.1.3 Cestode Infections
  5. 5.1.4 Trematode Infections
  6. 5.1.5 Schistosoma Infection
  7. 5.1.6 Others
  8. 5.2 Global Praziquantel Market Size by Application
  9. 5.2.1 Global Praziquantel Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Praziquantel Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Praziquantel Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Praziquantel Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Praziquantel Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Praziquantel Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Praziquantel Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Praziquantel Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Praziquantel Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Praziquantel Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Praziquantel Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Soparfin
  20. 6.4.1 Soparfin Company Information
  21. 6.4.2 Soparfin Business Overview
  22. 6.4.3 Soparfin Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Soparfin Praziquantel Product Portfolio
  24. 6.4.5 Soparfin Recent Developments
  25. 6.5 Shin Poong Pharm
  26. 6.5.1 Shin Poong Pharm Company Information
  27. 6.5.2 Shin Poong Pharm Business Overview
  28. 6.5.3 Shin Poong Pharm Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shin Poong Pharm Praziquantel Product Portfolio
  30. 6.5.5 Shin Poong Pharm Recent Developments
  31. 6.6 Richter Pharma
  32. 6.6.1 Richter Pharma Company Information
  33. 6.6.2 Richter Pharma Business Overview
  34. 6.6.3 Richter Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Richter Pharma Praziquantel Product Portfolio
  36. 6.6.5 Richter Pharma Recent Developments
  37. 6.7 Norbrook Laboratories
  38. 6.7.1 Norbrook Laboratories Company Information
  39. 6.7.2 Norbrook Laboratories Business Overview
  40. 6.7.3 Norbrook Laboratories Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Norbrook Laboratories Praziquantel Product Portfolio
  42. 6.7.5 Norbrook Laboratories Recent Developments
  43. 6.8 Merial
  44. 6.8.1 Merial Company Information
  45. 6.8.2 Merial Business Overview
  46. 6.8.3 Merial Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merial Praziquantel Product Portfolio
  48. 6.8.5 Merial Recent Developments
  49. 6.9 Mavlab Animal Health
  50. 6.9.1 Mavlab Animal Health Company Information
  51. 6.9.2 Mavlab Animal Health Business Overview
  52. 6.9.3 Mavlab Animal Health Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mavlab Animal Health Praziquantel Product Portfolio
  54. 6.9.5 Mavlab Animal Health Recent Developments
  55. 6.10 Lavet Pharmaceuticals
  56. 6.10.1 Lavet Pharmaceuticals Company Information
  57. 6.10.2 Lavet Pharmaceuticals Business Overview
  58. 6.10.3 Lavet Pharmaceuticals Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lavet Pharmaceuticals Praziquantel Product Portfolio
  60. 6.10.5 Lavet Pharmaceuticals Recent Developments
  61. 6.11 Kyron Pharma
  62. 6.11.1 Kyron Pharma Company Information
  63. 6.11.2 Kyron Pharma Business Overview
  64. 6.11.3 Kyron Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kyron Pharma Praziquantel Product Portfolio
  66. 6.11.5 Kyron Pharma Recent Developments
  67. 6.12 Krka
  68. 6.12.1 Krka Company Information
  69. 6.12.2 Krka Business Overview
  70. 6.12.3 Krka Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Krka Praziquantel Product Portfolio
  72. 6.12.5 Krka Recent Developments
  73. 6.13 Ecuphar
  74. 6.13.1 Ecuphar Company Information
  75. 6.13.2 Ecuphar Business Overview
  76. 6.13.3 Ecuphar Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ecuphar Praziquantel Product Portfolio
  78. 6.13.5 Ecuphar Recent Developments
  79. 6.14 Covetrus
  80. 6.14.1 Covetrus Company Information
  81. 6.14.2 Covetrus Business Overview
  82. 6.14.3 Covetrus Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Covetrus Praziquantel Product Portfolio
  84. 6.14.5 Covetrus Recent Developments
  85. 6.15 CiplaVet
  86. 6.15.1 CiplaVet Company Information
  87. 6.15.2 CiplaVet Business Overview
  88. 6.15.3 CiplaVet Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CiplaVet Praziquantel Product Portfolio
  90. 6.15.5 CiplaVet Recent Developments
  91. 6.16 Chanelle Pharma
  92. 6.16.1 Chanelle Pharma Company Information
  93. 6.16.2 Chanelle Pharma Business Overview
  94. 6.16.3 Chanelle Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chanelle Pharma Praziquantel Product Portfolio
  96. 6.16.5 Chanelle Pharma Recent Developments
  97. 6.17 Ceva Santé Animale
  98. 6.17.1 Ceva Santé Animale Company Information
  99. 6.17.2 Ceva Santé Animale Business Overview
  100. 6.17.3 Ceva Santé Animale Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Ceva Santé Animale Praziquantel Product Portfolio
  102. 6.17.5 Ceva Santé Animale Recent Developments
  103. 6.18 C and H Generics
  104. 6.18.1 C and H Generics Company Information
  105. 6.18.2 C and H Generics Business Overview
  106. 6.18.3 C and H Generics Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 C and H Generics Praziquantel Product Portfolio
  108. 6.18.5 C and H Generics Recent Developments
  109. 6.19 Auvex
  110. 6.19.1 Auvex Company Information
  111. 6.19.2 Auvex Business Overview
  112. 6.19.3 Auvex Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Auvex Praziquantel Product Portfolio
  114. 6.19.5 Auvex Recent Developments
  115. 6.20 AniMedica
  116. 6.20.1 AniMedica Company Information
  117. 6.20.2 AniMedica Business Overview
  118. 6.20.3 AniMedica Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 AniMedica Praziquantel Product Portfolio
  120. 6.20.5 AniMedica Recent Developments
7 North America by Country
  1. 7.1 North America Praziquantel Sales by Country
  2. 7.1.1 North America Praziquantel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Praziquantel Sales by Country (2021-2026)
  4. 7.1.3 North America Praziquantel Sales Forecast by Country (2027-2032)
  5. 7.2 North America Praziquantel Market Size by Country
  6. 7.2.1 North America Praziquantel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Praziquantel Market Size by Country (2021-2026)
  8. 7.2.3 North America Praziquantel Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Praziquantel Sales by Country
  2. 8.1.1 Europe Praziquantel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Praziquantel Sales by Country (2021-2026)
  4. 8.1.3 Europe Praziquantel Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Praziquantel Market Size by Country
  6. 8.2.1 Europe Praziquantel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Praziquantel Market Size by Country (2021-2026)
  8. 8.2.3 Europe Praziquantel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Praziquantel Sales by Country
  2. 9.1.1 Asia-Pacific Praziquantel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Praziquantel Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Praziquantel Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Praziquantel Market Size by Country
  6. 9.2.1 Asia-Pacific Praziquantel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Praziquantel Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Praziquantel Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Praziquantel Sales by Country
  2. 10.1.1 South America Praziquantel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Praziquantel Sales by Country (2021-2026)
  4. 10.1.3 South America Praziquantel Sales Forecast by Country (2027-2032)
  5. 10.2 South America Praziquantel Market Size by Country
  6. 10.2.1 South America Praziquantel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Praziquantel Market Size by Country (2021-2026)
  8. 10.2.3 South America Praziquantel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Praziquantel Sales by Country
  2. 11.1.1 Middle East and Africa Praziquantel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Praziquantel Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Praziquantel Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Praziquantel Market Size by Country
  6. 11.2.1 Middle East and Africa Praziquantel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Praziquantel Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Praziquantel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Praziquantel Value Chain Analysis
  2. 12.1.1 Praziquantel Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Praziquantel Production Mode & Process
  7. 12.2 Praziquantel Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Praziquantel Distributors
  10. 12.2.3 Praziquantel Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst